Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/10/22
Bolt Biotherapeutics to Present Ex Vivo Data Characterizing the Myeloid Cell Landscape in Solid Tumors at ASCO 2022GlobeNewsWire • 05/27/22
Bolt Biotherapeutics Reports First Quarter 2022 Financial Results and Provides Business HighlightsGlobeNewsWire • 05/12/22
Bolt Biotherapeutics Reports Four Quarter and Full Year 2021 Financial Results and Provides Business HighlightsGlobeNewsWire • 03/30/22
Bolt Biotherapeutics Reports Interim BDC-1001 Phase 1/2 Data Demonstrating a Safe and Well-tolerated Profile and Emerging Clinical Activity at the ESMO Immuno-Oncology Congress 2021GlobeNewsWire • 12/06/21
Bolt Biotherapeutics to Present Interim Clinical Data on BDC-1001 Phase 1/2 Clinical Trial at ESMO Immuno-Oncology Congress 2021GlobeNewsWire • 12/02/21
Bolt Biotherapeutics Presents New Preclinical Data on Three Pipeline Programs at Society for Immunotherapy of Cancer (SITC) Annual MeetingGlobeNewsWire • 11/12/21
Bolt Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Business HighlightsGlobeNewsWire • 11/09/21
Bolt Biotherapeutics to Present Updates on Three Pipeline Programs at the 2021 Society for Immunotherapy of Cancer Annual Meeting (SITC)GlobeNewsWire • 10/01/21
Bolt Biotherapeutics Announces Clinical Collaboration with Bristol Myers Squibb to Study BDC-1001 in Combination with Opdivo® for Treatment of HER2-Expressing Solid TumorsGlobeNewsWire • 09/08/21
Bolt Biotherapeutics to Participate in Upcoming September Investor ConferencesGlobeNewsWire • 09/02/21
Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC ProgramsPRNewsWire • 08/27/21
Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC ProgramsGlobeNewsWire • 08/26/21
Bolt Biotherapeutics Presents Preliminary Results from Phase 1/2 Trial of Lead HER2-targeting Boltbody™ ISAC BDC-1001 at ASCO 2021GlobeNewsWire • 06/04/21